Raleigh drugmaker slashes workforce as biotech downturn deepens

The drugmaker is cutting one-third of its U.S. commercial workforce as part of a plan to save $50 million. The move comes as the biotech industry sees cuts across the board as the highs of the pandemic fade away.
Click here to view original post

Click here to view North Carolina Biotech Networks Trending News